Clinical Trial Update: First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

First-in-human Phase 1/2 trial of EGL-001 in adults with selected advanced or metastatic solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• EGL-001

Snippet

Sponsor: Egle Therapeutics | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: RECRUITING